Erick Gamelin
Corporate Officer/Principal bij ACRIVON THERAPEUTICS, INC.
Vermogen: 153 874 $ op 30-04-2024
Profiel
Erick Gamelin is currently the Chief Development Officer at Acrivon Therapeutics, Inc. He previously held positions as the Vice President-Oncology at Dynavax Technologies Corp., Vice President at MacroGenics, Inc., and Chief Medical Officer at Step Pharma SAS.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 14-02-2024 | 18 167 ( 0.06% ) | 153 874 $ | 30-04-2024 |
Actieve functies van Erick Gamelin
| Bedrijven | Functie | Begin |
|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Corporate Officer/Principal | 03-01-2024 |
Eerdere bekende functies van Erick Gamelin
| Bedrijven | Functie | Einde |
|---|---|---|
Step Pharma SAS
 Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Chief Tech/Sci/R&D Officer | 01-01-2021 |
| DYNAVAX TECHNOLOGIES CORPORATION | Corporate Officer/Principal | 01-10-2019 |
| MACROGENICS, INC. | Corporate Officer/Principal | 01-03-2018 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
| MACROGENICS, INC. | Health Technology |
| ACRIVON THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Health Technology |
